This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: University of Florida Research Foundation Inc., Scripps Research Institute. Active years: 2020-2024.
Company Filing History:
3 out of 3,050 
1 out of 1,206 
Years Active: 2020-2024
Title: Daiqing Liao: Innovator in Cancer Treatment
Introduction
Daiqing Liao is a prominent inventor based in Gainesville, FL (US), known for his significant contributions to cancer treatment through innovative research and development. He holds a total of 3 patents, showcasing his dedication to advancing medical science.
Latest Patents
Liao's latest patents include a polypeptide inhibitor of de novo lipogenesis in cancer cells. This invention discloses a method for treating cancer by administering a composition that includes a polypeptide with an amino acid sequence corresponding to the C-terminal SUMO-interacting motif (SIM2) of a DAXX protein. The polypeptide competes with endogenous DAXX for binding to SUMO, providing a novel approach to cancer treatment. Another significant patent involves HDAC inhibitor compounds and methods of treatment. This invention describes hydrazide-containing compounds with therapeutic activity, aimed at treating disorders such as cancer, tumors, and cell proliferation-related disorders.
Career Highlights
Throughout his career, Daiqing Liao has worked with esteemed organizations, including the University of Florida Research Foundation and The Scripps Research Institute. His work has been instrumental in developing new therapeutic strategies for cancer treatment.
Collaborations
Liao has collaborated with notable colleagues, including William R. Roush and Ryan L. Stowe, further enhancing the impact of his research in the field of cancer therapy.
Conclusion
Daiqing Liao's innovative work in cancer treatment through his patents and collaborations highlights his commitment to improving patient outcomes. His contributions continue to pave the way for advancements in medical science.